BIRO Fundamental Analysis - ESTRIMA SPA

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to BIRO. BIRO was compared to 32 industry peers in the Automobiles industry. BIRO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, BIRO is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BIRO has reported negative net income.

In the past year BIRO had a positive cash flow from operations.

BIRO had negative earnings in each of the past 5 years.

BIRO had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -9.93%, BIRO is not doing good in the industry: 70.97% of the companies in the same industry are doing better.

With a Return On Equity value of -41.27%, BIRO is not doing good in the industry: 70.97% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-9.93%
ROE	-41.27%
ROIC	N/A

ROA(3y)-17.96%

ROA(5y)N/A

ROE(3y)-73.17%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 20.96%, BIRO is in the better half of the industry, outperforming 64.52% of the companies in the same industry.

In the last couple of years the Gross Margin of BIRO has grown nicely.

The Profit Margin and Operating Margin are not available for BIRO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	20.96%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y15.33%

GM growth 5Y4.17%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BIRO does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BIRO remains at a similar level compared to 1 year ago.

Compared to 5 years ago, BIRO has about the same amount of shares outstanding.

BIRO has a worse debt/assets ratio than last year.

2.2 Solvency

BIRO has an Altman-Z score of 0.56. This is a bad value and indicates that BIRO is not financially healthy and even has some risk of bankruptcy.

BIRO has a Altman-Z score of 0.56. This is in the lower half of the industry: BIRO underperforms 67.74% of its industry peers.

The Debt to FCF ratio of BIRO is 3.90, which is a good value as it means it would take BIRO, 3.90 years of fcf income to pay off all of its debts.

BIRO has a better Debt to FCF ratio (3.90) than 83.87% of its industry peers.

A Debt/Equity ratio of 0.97 indicates that BIRO is somewhat dependend on debt financing.

BIRO's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. BIRO is outperformed by 74.19% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.97
Debt/FCF	3.9
Altman-Z	0.56

ROIC/WACCN/A

WACC7.14%

2.3 Liquidity

A Current Ratio of 1.26 indicates that BIRO should not have too much problems paying its short term obligations.

The Current ratio of BIRO (1.26) is comparable to the rest of the industry.

A Quick Ratio of 0.77 indicates that BIRO may have some problems paying its short term obligations.

With a Quick ratio value of 0.77, BIRO is not doing good in the industry: 77.42% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.26
Quick Ratio	0.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.03% over the past year.

Looking at the last year, BIRO shows a very negative growth in Revenue. The Revenue has decreased by -22.99% in the last year.

Measured over the past years, BIRO shows a very strong growth in Revenue. The Revenue has been growing by 40.21% on average per year.

EPS 1Y (TTM)82.03%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%87.34%

Revenue 1Y (TTM)-22.99%

Revenue growth 3Y54.95%

Revenue growth 5Y40.21%

Sales Q2Q%-33.9%

3.2 Future

BIRO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.35% yearly.

The Revenue is expected to grow by 3.69% on average over the next years.

EPS Next Y50%

EPS Next 2Y22.47%

EPS Next 3Y19.35%

EPS Next 5YN/A

Revenue Next Year-18.57%

Revenue Next 2Y-7.3%

Revenue Next 3Y0%

Revenue Next 5Y3.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BIRO. In the last year negative earnings were reported.

Also next year BIRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

61.29% of the companies in the same industry are cheaper than BIRO, based on the Enterprise Value to EBITDA ratio.

Based on the Price/Free Cash Flow ratio, BIRO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	3.37
EV/EBITDA	24.05

4.3 Compensation for Growth

A more expensive valuation may be justified as BIRO's earnings are expected to grow with 19.35% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y22.47%

EPS Next 3Y19.35%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BIRO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ESTRIMA SPA

BIT:BIRO (10/1/2025, 7:00:00 PM)

0.201

0 (-1.47%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupAutomobiles & Components

GICS IndustryAutomobiles

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners3.94%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap5.98M

Revenue(TTM)33.33M

Net Income(TTM)-2.14M

Analysts37.78

Price Target0.2 (-0.5%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP-0.03%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)16.67%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-25.85%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.18
P/FCF	3.37
P/OCF	2.69
P/B	1.15
P/tB	1.32
EV/EBITDA	24.05

EPS(TTM)-0.15

EYN/A

EPS(NY)-0.05

Fwd EYN/A

FCF(TTM)0.06

FCFY29.66%

OCF(TTM)0.07

OCFY37.19%

SpS1.12

BVpS0.17

TBVpS0.15

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-9.93%
ROE	-41.27%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	20.96%
FCFM	5.32%

ROA(3y)-17.96%

ROA(5y)N/A

ROE(3y)-73.17%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y15.33%

GM growth 5Y4.17%

F-Score5

Asset Turnover1.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0.97
Debt/FCF	3.9
Debt/EBITDA	14.53
Cap/Depr	34.03%
Cap/Sales	1.35%
Interest Coverage	N/A
Cash Conversion	639.13%
Profit Quality	N/A
Current Ratio	1.26
Quick Ratio	0.77
Altman-Z	0.56

F-Score5

WACC7.14%

ROIC/WACCN/A

Cap/Depr(3y)101.11%

Cap/Depr(5y)147.83%

Cap/Sales(3y)4.41%

Cap/Sales(5y)7.46%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)82.03%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%87.34%

EPS Next Y50%

EPS Next 2Y22.47%

EPS Next 3Y19.35%

EPS Next 5YN/A

Revenue 1Y (TTM)-22.99%

Revenue growth 3Y54.95%

Revenue growth 5Y40.21%

Sales Q2Q%-33.9%

Revenue Next Year-18.57%

Revenue Next 2Y-7.3%

Revenue Next 3Y0%

Revenue Next 5Y3.69%

EBIT growth 1Y72.27%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year68.75%

EBIT Next 3Y29.81%

EBIT Next 5Y36.28%

FCF growth 1Y143.87%

FCF growth 3YN/A

FCF growth 5Y22.2%

OCF growth 1Y215.13%

OCF growth 3YN/A

OCF growth 5Y21.22%

ESTRIMA SPA / BIRO.MI FAQ

What is the fundamental rating for BIRO stock?

ChartMill assigns a fundamental rating of 2 / 10 to BIRO.MI.

What is the valuation status of ESTRIMA SPA (BIRO.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to ESTRIMA SPA (BIRO.MI). This can be considered as Overvalued.

How profitable is ESTRIMA SPA (BIRO.MI) stock?

ESTRIMA SPA (BIRO.MI) has a profitability rating of 1 / 10.

Is the dividend of ESTRIMA SPA sustainable?

The dividend rating of ESTRIMA SPA (BIRO.MI) is 0 / 10 and the dividend payout ratio is -0.03%.

ESTRIMA SPA (BIRO.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ESTRIMA SPA / BIRO.MI FAQ

What is the fundamental rating for BIRO stock?

What is the valuation status of ESTRIMA SPA (BIRO.MI) stock?

How profitable is ESTRIMA SPA (BIRO.MI) stock?

Is the dividend of ESTRIMA SPA sustainable?